市場調査レポート
商品コード
1386270
神経バイオマーカー市場レポート:2030年までの動向、予測、競合分析Neurological Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
神経バイオマーカー市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
神経バイオマーカーの動向と予測
世界の神経バイオマーカー市場は、2024年から2030年までのCAGRが11.7%で、2030年までに推定147億米ドルに達すると予想されます。この市場の主な促進要因は、リキッドバイオプシーの採用拡大、神経バイオマーカー開発における人工知能(AI)の活用拡大、個別化医療に対する需要の高まりです。世界の神経バイオマーカー市場の将来は、病院・病院研究所、独立系臨床診断センター、研究機関の各市場における機会で有望視されています。
神経バイオマーカー市場の洞察
Lucintelは、神経疾患の有病率の増加により、プロテオミクスが予測期間中に最も高い成長を遂げると予測しています。
この市場の中では、病院と病院検査室が神経疾患の診断サービスを提供する主要なプロバイダーとして考えられているため、最も高い成長を示すことになるでしょう。
北米は、アルツハイマー病、パーキンソン病、多発性硬化症などの神経疾患の有病率が高く、同地域のヘルスケア支出が増加していることから、予測期間中も最大地域であり続けると思われます。
Neurological Biomarker Trends and Forecast
The future of the global neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets. The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030 with a CAGR of 11.7% from 2024 to 2030. The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.
A more than 150-page report is developed to help in your business decisions.
Neurological Biomarker by Segment
The study includes a forecast for the global neurological biomarker by type, application, end use, and region.
Neurological Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Neurological Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Neurological Biomarker Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Neurological Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Neurological Biomarker Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurological biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurological biomarker companies profiled in this report include-
Neurological Biomarker Market Insights
Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.
Within this market, hospitals and hospital laboratories will witness the highest growth as they are considered as a primary providers of diagnostic services for neurological disorders.
North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.
Features of the Global Neurological Biomarker Market
Market Size Estimates: Neurological biomarker market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Neurological biomarker market size by type, application, end use, and region in terms of value ($B).
Regional Analysis: Neurological biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the neurological biomarker market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurological biomarker market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the neurological biomarker market size?
Answer: The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030.
Q.2 What is the growth forecast for neurological biomarker market?
Answer: The global neurological biomarker market is expected to grow with a CAGR of 11.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the neurological biomarker market?
Answer: The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.
Q4. What are the major segments for neurological biomarker market?
Answer: The future of the neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets.
Q5. Who are the key neurological biomarker market companies?
Answer: Some of the key neurological biomarker companies are as follows:
Q6. Which neurological biomarker market segment will be the largest in future?
Answer: Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.
Q7. In neurological biomarker market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.